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1. Introduction 
Most organisms and tissues contain two distinct 
types of CAMP-independent protein kinases active on 
casein (casein kinases), differing for both molecular 
structure and nucleotide specificity and affecting dif- 
ferent phosphorylation sites (review [ 11): unlike the 
monomeric type I casein kinase, using only ATP and 
affecting only Ser residues of casein, the oligomeric 
type II casein kinases can utilize also GTP and affect 
both Thr and Ser residues; consequently they are also 
termed casein kinases A and G [2] or casein kinases S 
and TS [3,4], respectively. 
protein substrate and non-competitive toward ATP. 
The inhibitory power, however, is not only depen- 
dent on the concentration of the substrate but also 
on its nature and, at fixed concentrations of heparin 
and protein substrate, on the amount of added casein 
kinase which can overcome the inhibition so that the 
Iso values are significantly variable as a function of 
Ck-TS concentration. 
An additional peculiar feature of the type II casein 
kinases from rabbit reticulocytes [5] and erythrocytes 
[6], bovine adrenal cortex [2], Morris hepatoma [7] 
and rat liver nuclei [8] appears to be their capability 
of undergoing a very efficient and specific inhibition 
by heparin. Apparently no other protein kinases, 
including the type I casein kinases, are affected by 
heparin [5], with the exception of phosphorylase 
kinase which, however, is stimulated rather than 
inhibited [9]. 
Our experiments also disclosed an inhibition by 
heparin of the monomeric type I casein kinase, Ck-S, 
which was expected to be insensitive to it: such an 
inhibition however requires concentrations of heparin 
200-300-times higher than those effective on CLTS 
and occurs through a different mechanism, as it can 
be apparently reversed by high ATP concentration 
but neither by casein nor by phosvitin. 
2. Experimental 
The mechanism by which heparin inhibits the 
type II casein kinases is not yet elucidated. A compe- 
tition between heparin and the protein substrate 
casein was reported in [2,5,8] but not in [6] and the 
concentrations of heparin inducing 50% inhibition 
(Zso) were found to be significantly different. Heparin 
inhibition might occur through an allosteric mecha- 
nism [l]. 
Here, we have studied the effect of heparin on two 
rat liver cytosol casein kinases, Ck-TS and Ck-S, cor- 
responding to the type II and type I, respectively 
[IO]. The results obtained indicate that CLTS is effi- 
ciently inhibited by very low heparin concentrations 
(S-20 nM) in a reversible way and by a mechanism 
which is apparently competitive with respect to the 
Casein kinases TS and S (Ck-TS and Ck-S) were 
both prepared from rat liver cytosol as in [lo]. Ck-TS 
was purified to homogeneity, as judged by SDS- 
polyacrylamide gel electrophoresis. Under non-dena- 
turing conditions it approximated 130 000 Mr. Ck-S 
was subjected to a second Sepharose 6B gel filtration 
in the presence of 0.01% Brij 35 in order to remove 
from it any traces of contaminating Ck-TS. It phos- 
phorylated casein exclusively at Seryl residues and 
exhibited -35 000 M, both by gel filtration under 
non-denaturing conditions and by SDS-polyacryl- 
amide gel electrophoresis. 
Casein kinase activity was routinely tested on 
whole casein as in [lo]. In the experiments with 
CCTS, 100 mM NaCl was also added to the incuba- 
tion medium. In some experiments phosvitin was 
replaced for casein. In all the experiments the reac- 
tion rate was linear with time. Heparin, when present, 
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was added with the protein substrate and the reaction 
was started by the addition of the enzyme. The con- 
centrations of the protein substrates, heparin and 
CGTS are detailed in the legends of the figures. 
Phosphorylation of endogenous proteins was stud- 
ied by substituting model substrates with a prepara- 
tion of lyophilized rat liver cytosol (105 000 X g 
clear supernatant dialyzed against water before lyo- 
philization). The concentration of cytosolic proteins 
in the incubation medium was 1.25 mg per ml, and 
the incubation time was 15 min. The separation and 
autoradiography of the labeled proteins was per- 
formed by 11% SDS-polyacrylamide gel electropho- 
resis according to [ 111, essentially as in [lo]. 
Materials: Whole casein was kindly provided by 
Dr B. Ribadeau-Dumas (Jouy-en-Josas). Phosvitin was 
from Sigma. Heparin (from hog intestinal mucosa) 
was from Serva. Synthetic peptides (Arg)*-Gly- 
Ala-(Arg), and (Arg)4-Tyr-Gly-Ser-(Arg)6, revers- 
ing heparin inhibition, were kindly provided by Dr F. 
Marchiori (Centro Biopolimeri, CNR, Padova). All 
other chemicals were from either Merck or Serva. 
3. Results 
The inhibition of rat liver cytosol Ck-TS and Ck-S 
by increasing concentrations of heparin under differ- 
ent conditions is illustrated in fig.lA,B. While lOO- 
300 ng heparin/ml are usually sufficient for depress- 
ing the Ck-TS activity on casein quite significantly, 
they have no effect, or maybe a slightly stimulatory 
effect, on Ck-S. However if the concentration of 
heparin is raised to 50 pg/ml or more also CLS is 
drastically inhibited. With both enzymes and espe- 
cially with Ck-S the phosphorylation of phosvitin is 
more sensitive than that of casein to heparin inhibi- 
tion. A complete prevention of heparin inhibition is 
obtained upon addition of Arg-rich synthetic deca 
and dodecapeptides, as occurs with polyamines and 
histones [9]. However, the addition of 0.02% SDS, 
which is expected to dissociate the oligomeric struc- 
ture of Ck-TS and depresses its activity to -50% does 
not prevent but actually enhances quite significantly 
the inhibitory effect of heparin (not shown). 
While casein can reverse in a competitive way the 
inhibition of Ck-TS by heparin, no competition 
between casein and heparin could be evidenced with 
Ck-S (fig.2). Quite similar results were obtained by 
replacing casein with phosvitin (not shown). 
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The effect of increasing ATP was also different 
with the 2 enzymes as a reversal of heparin inhibition 
by high ATP concentrations could be detected with 
Ck-S but not with Ck-TS (fig.2B,D). However, the 
ATP kinetics with Ck-S and heparin constantly gave 
rise to irregular biphasic double reciprocal plots hin- 
dering a clear-out definition of the kinetic constants 
(fig.2D). 
The extent of Ck-TS inhibition by heparin is not 
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Fig.1. Effect of low (A) and high (B) concentrations of hepa- 
rin on the activity of rat liver casein kinases. (-) CL-TS 
(2.2 ng/ml) plus casein (0); Ck-TS (2.2 ng/ml) plus casein plus 
synthetic peptide (Arg),-Gly-Ala-(Arg), (A); Ck-TS 
(2.2 ng/ml) plus phosvitin (x); Ck-TS (8.8 fig/ml) plus casein 
(0); Ck-TS (17.6 pg/ml) plus casein (a). (. .) Ck-S plus casein 
(m), plus casein plus (Arg),-Gly-Ala-(Arg), (A), plus phos- 
vitin (0). The concentration of CL-S was identical in aB 
experiments (-2.2 pg/ml) and that of the protein substrates 
was 2.5 mg/ml. The peptide (Arg),-Gly-Ala-(Arg), was 
0.2 mM in A and 0.3 mM in B. 
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Fig.2. Double reciprocal plots for the inhibition of CL-TS 
(A,B) and Ck-S (C,D) by low and high concentrations of hep- 
arin, respectively. In A and C casein was varied from 1.25- 
15 mg/ml while ATP was held constant at 60 PM. In B and D 
ATP was varied from 6.2-200 PM while casein concentration 
was held constant at 2.5 mg/ml. The molarity of whole casein 
was calculated assuming av.Mr = 24 000. In A and B the hep- 
arin concentrations were: 0 ng/ml (o), 150 ng/ml (o) and 
300 ng/ml (X), while in C and D the heparin concentrations 
were: 0 pg/ml (o), 30 pg/ml (x)and 50 rg/ml (0). 
only dependent on the concentration and the nature 
of the protein substrate but also on the amount of 
enzyme. Inhibition curves are significantly shifted 
toward higher heparin concentrations by increasing 
the concentration of Ck-TS (fig.lA). Consequently 
the Is,values are not constant but they also increase 
with the concentration of the enzyme. Such an effect 
was expectable as the amount of heparin effective on 
Ck-TS are nearly stoichiometric with the enzyme. By 
keeping unchanged the concentrations of heparin and 
casein, the inhibitory effect can be gradually over- 
come by increasing the amount of Ck-TS (fig.3). From 
this experiment it was calculated that with 104 PM 
casein an 80% inhibition occurs when the heparin/ 
Ck-TS molar ratio approaches 2.3 (assuming M,-values 
for heparin and Ck-TS of 14 000 [ 121 and 130 000 
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Fig.3. Decrease of heparin inhibitory efficiency by increasing 
Ck-TS. Casein and heparin concentrations were held constant 
at 2.5 mg/ml and 300 ng/ml, respectively, while the concen- 
tration of CL-TS was varied from 8.6-154.8 nM, assuming 
M, = 130 000 [lo]. The molar ratio Ck-TS/heparin was calcu- 
lated assuming for heparin av.M, 14 000 [ 121. 
[lo], respectively). However, considering that Ck-TS 
is a type II casein kinase with 2 catalytic subunits/ 
molecule [ 10,131, the molar ratio heparimcatalytic 
subunit promoting an almost complete inhibition 
turns out to be slightly higher than one. Inhibition is 
half-maximal with an heparin/catalytic subunit molar 
ratio as low as 0.1, suggesting that a single heparin 
molecule interacts with more than one catalytic sub- 
unit. 
The competition between heparin and casein and 
the enhancement of heparin inhibition by replacing 
phosvitin for casein supported the view that the 
inhibitory power of heparin might be critically depen- 
dent also on the nature of the endogenous protein 
substrates of Ck-TS. To check this point the effect of 
heparin on the phosphorylation of rat liver cytosolic 
proteins by Ck-TS has been studied. A heparin con- 
centration nearly abolishing the phosphorylation of 
104 PM casein, under comparable conditions depresses 
only the phosphorylation of a 25 000 Mr band, corre- 
sponding to the B-subunit of Ck-TS [IO], while the 
intensities of the remaining radiolabeled bands are 
quite unaffected (fig.4). By increasing the concentra- 
tion of heparin to 30 and 90 pg/ml also the other 
bands either disappear or become fainter: a couple of 
bands however are still detectable at a heparin con- 
centration which is already effective on the ‘heparin- 
resistant’ Ck-S when tested on phosvitin (see fig.1 B). 
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Fig.4. Effect of heparin on the phosphorylation of rat liver cytosol proteins by Ck-TS. The conditions for the phosphorylation 
experiments and subsequent gel electrophoresis in SDS are either detailed or quoted in section 2. The autoradiograms of the dried 
gels are presented. In the casein phosphorylation experiments (lanes l-2) rat liver cytosol (1 mg/ml) was also added besides casein 
(2.5 mg/ml) and only l/S of the whole radiolabeled protein was subjected to gel electrophoresis and autoradiographed for 5 h. In 
all other experiments (lanes 3-10) the whole amounts of radiolabeled proteins were subjected to gel electrophoresis and the 
exposure time of autoradiographies was 36 h. The M,-values of the main radiolabeled proteins were estimated by calibration of the 
SDS gels with the following marker proteins: glycogen phosphorylase (98 000), bovine serum albumin (67 000), ovalbumin 
(45 000), lactate dehydrogenase (36 000), trypsinogen (24 000) and ribonuclease (13 700). A linear plot was obtained of subunit 
M,-values (log scale) vs relative migration (percentage). 
4. Discussion 
These data support the following main conclusions: 
(1) Rat liver cytosol casein kinase TS (Ck-TS) is 
efficiently and reversibly inhibited by nM levels of 
heparin which are quite ineffective on casein kinase S 
(Ck-S) from the same source. 
(2) A competition between heparin and casein (or 
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phosvitin) for the protein substrate binding site of 
Ck-TS is suggested by kinetic experiments. In the 
presence of 100 PM casein, however, an almost com- 
plete inhibition can be promoted by just 20 nM hepa- 
rin. Under these conditions the heparin/Ck-TS cata- 
lytic subunit molar ratio approaches one, suggesting 
that virtually all the heparin molecules are interacting 
with an equivalent number of catalytic subunits. 
Accordingly, by increasing the Ck-TS concentration 
the inhibition is gradually overcome. The finding that 
a 50% inhibition is still observed at an heparin/cata- 
lytic subunit molar ratio -0.1 would indicate that 
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whenever Ck-TS is in molar excess, a single heparin 
molecule can interact with more than one catalytic 
subunit of the enzyme*. 
(3) By increasing heparin to 4-8 PM (which is still 
compatible with physiological conditions) also the 
type I monomeric Ck-S is drastically inhibited. Such 
an inhibition however is no more competitive with 
respect to the protein substrate. However, the inhibi- 
tion patterns at variable ATP concentration exhibited 
remarkable irregularities hindering an unambiguous 
definition of the inhibition type. Nevertheless, by 
increasing the [ATP] over 100 PM a reproducible 
reversal of heparin inhibition was constantly observed 
(see fig.2D). 
(4) The extent of Ck-TS inhibition by heparin is 
largely dependent also on the nature of the protein 
substrate: under comparable conditions the phospho- 
rylation of phosvitin is depressed more than that of 
casein, while, as an average, the endogenous cytosolic 
substrates are much less sensitive to heparin than are 
the model substrates, with the noticeable exception 
of a 25 000 Mr band corresponding to the ‘autophos- 
phorylatable’ P-subunit of Ck-TS itself. 
The above data while confirming that in vitro hep- 
arin provides a quick and very suitable tool for dis- 
criminating between the ‘heparin-sensitive’ type II 
and the ‘heparin-insensitive’ type I casein kinases, also 
disclose the possibility that under physiological con- 
ditions the specificity of heparin inhibition may 
not be so clearcut, giving possibly rise to a discrimina- 
tion among the several potential targets of casein 
kinases rather than to the mere switching off of 
type II casein kinases. 
Of course any such involvement of heparin and/or 
* The finding that antithrombin III, a protein with high affin- 
ity for heparin [ 141 reversing also the effect of heparin on 
phosphorylase kinase (91, cannot prevent, under compar- 
able conditions, the inhibition of Ck-TS (unpublished), 
argues that the heparin molecules or domains responsible 
for the inhibition of CL-TS are distinct from those involved 
in its anticoagulant effect. In particular, it is possible that 
the antiCk-TS activity of heparin resides in the so-called 
Low Affinity fraction (LA-heparin) rather than in the frac- 
tion exhibiting high affinity for antithrombin III (HA-hepa- 
rin, corresponding to -1/3rd of the molecules) [14] 
heparin-like compounds in the regulation of casein 
kinase activities in vivo preliminarily requires that 
these acidic glycosaminoglycans can actually reach 
the subcellular compartments harbouring the enzyme. 
To our knowledge such an assumption is not proven: 
however, some evidence about the intracellular loca- 
tion of dextran sulphates and their internalization by 
cultured cells are available (see [ 141). 
It should be finally pointed out that the mecha- 
nisms by which heparin affects the two rat liver casein 
kinases are likely to be different since heparin, acting 
at low concentrations as a competitive inhibitor of 
Ck-TS with respect to the protein substrate, behaves 
at higher concentrations as a non-competitive inhibi- 
tor of CLS with respect to the same protein sub- 
strates. This finding by the way would be consistent 
with the view that the protein substrate binding sites 
of CLTS and Ck-S are different, as suggested by the 
reports that these two kinases recognize different 
sites in casein fractions [4,10,15]. However, the find- 
ing that high ATP concentrations can reverse the 
inhibition of Ck-S suggests that heparin might also 
interact with the nucleotide binding site of this kinase, 
which has been shown to be also different from that 
of Ck-TS [ 171. To sum up therefore, the heparin 
molecules might display a double binding capacity 
toward both the protein substrate site of Ck-TS and 
the nucleotide site of Ck-S, exhibiting however a 
much higher affinity for the former than for the 
latter. 
Alternatively, the heparin inhibition of Ck-TS 
might occur through an allosteric mechanism, still 
consistent with the observed competition by casein 
and phosvitin, assuming either a reciprocal influence 
between the catalytic and regulatory sites or even a 
mere subtraction of heparin by the protein substrate 
itself (though a positive interaction between 2 poly- 
anions like phosvitin and heparin would be quite 
unexpected). Such a possibility would be consistent 
with the oligomeric structure of CL-TS and with the 
finding that relatively huge amounts of protein sub- 
strate are required for overcoming the effect of cata- 
lytic amounts of heparin, whose molecules lack any 
close similarities with casein as expected for a typical 
competitive inhibitor of a casein kinase [ 11. However, 
no kinetic evidence supporting the allosteric hypothe- 
sis is available. Moreover, in the presence of SDS the 
heparin inhibition was not abolished, as expected if it 
had required the integrity of the quaternary structure, 
but actually it was significantly enhanced. 
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